Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.995
+0.065 (2.22%)
At close: Apr 16, 2026, 4:00 PM EDT
2.990
-0.005 (-0.17%)
After-hours: Apr 16, 2026, 6:27 PM EDT
CNTB Revenue
In the year 2025, Connect Biopharma Holdings had annual revenue of $64.00K, down -99.75%.
Revenue (ttm)
$64.00K
Revenue Growth
-99.75%
P/S Ratio
2,640.60
Revenue / Employee
$1,000
Employees
64
Market Cap
169.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 64.00K | -25.97M | -99.75% |
| Dec 31, 2024 | 26.03M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Jan 1, 2022 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Heron Therapeutics | 154.90M |
| Agenus | 114.20M |
| Black Diamond Therapeutics | 70.00M |
| Fate Therapeutics | 6.65M |
| Cartesian Therapeutics | 2.80M |
| Oramed Pharmaceuticals | 2.00M |
CNTB News
- 16 days ago - Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update - GlobeNewsWire
- 17 days ago - Connect Biopharma Announces $20.2 Million Private Placement Financing - GlobeNewsWire
- 17 days ago - Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study - GlobeNewsWire
- 17 days ago - Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD - GlobeNewsWire
- 5 weeks ago - Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting - GlobeNewsWire
- 6 weeks ago - Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 3 months ago - Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026 - GlobeNewsWire